Project cooperationUpdated on 20 August 2025
Ionic liquid transdermal system (ILTS) technology
About
In order to allow various compounds to be available as topical formulations, MEDRx capitalizes on liquid salt forms (ionic liquid, or IL), which keep liquid form at body temperature.
Ionic liquid transdermal system (ILTS) provides adequate solubility of various APIs and achieves stable liquefaction by means of producing liquid salt forms.
MEDRx ILTS technology presents:
1. IL library consisting of the combinations of proven compounds to apply on human bodies safely.
2. Know-how to design IL-based preparations so that the solubility and absorbability of the API is optimized.
3. Know-how to prepare transdermal formulations to remain IL-based performance (e.g., patches and ointments).
ILTS patent portfolio covers various transdermal formulations for wide range of APIs.
Organisation
Company (SME/startup) / 中小企業・スタートアップ
431-7 Nishiyama, Higashikagawa city, Kagawa, Japan
Similar opportunities
Project cooperation
Project cooperation